Table Of Content

VIER Author Index Volumes 35 and 36 A D Abdelmawla AH, 36:77 D’Amico C, 35:107 Abe Y, 35:55 de Certaines JD, 35:139 Akeson A, 36:155 De Raeve H, 35:167 Antona A, 35:107 Debon C, 36:223 Antos M, 36:73 Decrinis M, 35:203, 36:205 Arce A, 35:69 Demedts M, 35:167 Arnot MI, 36:29 Dever JA, 36:185 Attolini L, 35:211 Di Pasquale P, 35:107 Dickinson RG, 36:131 Domanovits H, 35:203 B Duan J, 35:83 Baersch G, 36:63 Durham SK, 35:3 Bagger JP, 36:13 Balsa D, 36:53 Bateson AN, 36:29 F Bazan E, 36:81 Fernandes BH, 35:83 Belardinelli L, 35:203 Ferrando R, 36:53 Bellanca L, 35:107 Forn J, 36:53 Fosbraey P, 35:159 Benveniste J, 36:219 Beretz A, 36:69 Frobert O, 36:13 Beume R, 35:91 Frdlich JC, 36:63 Black SC, 35:179 Fukushima S, 35:19 Bohnke R, 36:155 Bradshaw CM, 36:77 Breschi MC, 35:131 G Breyssens A, 35:167 Gabel RA, 36:189 Brien JF, 36:97 Gantenbein M, 35:211 Bruguerolle B, 35:211 Garcia-Rafanell J, 36:53 Bucca V, 35:107 Gill JM, 36:171 Giral M, 36:53 Goetz A, 36:171 C Gregersen H, 36:13 Calderone V, 35:131 Grossmann V, 36:199 Grzybowski J, 36:73 Cam MC, 35:111 Capezzone de Joannon A, 36:21 Guarini S, 35:101 Caprino L, 35:153 Cassel GE, 35:159 Catalin J, 35:211 H Chagneau F, 35:139 Haefner D, 35:91 Clottens FL, 35:167 Han SB, 36:33, 36:163 Constantinou CE, 35:191 Hariton C, 36:223 Coupar IM, 36:147 Hashimoto M, 35:19, 36:45 Journal of Pharmacological and Toxicological Methods 36, 229-231 (1996) © 1996 Elsevier Science Inc. 1056-8719/96/$15.00 655 Avenue of the Americas, New York, NY 10010 Hatzelmann A, 35:91 Levasseur R, 35:139 Heifetz CL, 36:185 Licata G, 35:107 Hirano H, 36:45 Lindner W, 36:205 Hirohashi M, 35:25 Liu L, 36:147 Hong DH, 36:163 Liu WT, 35:121 Hope W, 36:137 Lutz MW, 36:171 Hornfeldt BJ, 35:45 Hunder G, 36:211 Hyun BH, 36:33 M Madeira VMC, 35:35 Malta TE, 36:185 I Mangano G, 36:21 Ichikawa N, 36:45 Marks GS, 36:97 Igié R, 35:63 Martin IL, 36:29 Inczeffy Z, 35:145 Martin V, 36:69 Irving P, 36:171 Martinotti E, 35:131 Ishida Y, 35:19 Masumura S, 35:19, 36:45 Ishisu R, 35:55 Mather LE, 36:123 lsokawa S, 35:19 McLeod AL, 35:83 Issaevitch T, 35:223 McNeill JH, 35:111 Iwamoto K, 36:45 Megill JR, 35:3 Izzo AA, 36:219 Merlos M, 36:53 Mikkelsen EO, 36:13 Milanese C, 36:21 Min BK, 36:33 Jaquenod M, 36:123 Momose K, 35:11, 35:19 Jaramillo J, 35:83 Moran JH, 36:41 Joannides ET, 36:185 Moreno AJM, 35:35 Johnson RG, 36:81 Morgan PH, 36:171 Jung GL, 35:83 Murakami E, 35:19 K N Kang JS, 36:163 Nakano T, 35:55 Kasper K, 35:203, 36:205 Nakatsu K, 36:97 Kastner P, 36:155 Nakayama K, 35:19 Kenakin TP, 36:171 Naora K, 36:45 Kim HM, 36:33, 36:163 Nemery B, 35:167 Kim MS, 36:163 Nicholls PJ, 35:217 King AR, 36:131 Nomura M, 35:25 Kitano Y, 35:25 Nyborg NCB, 36:13 Kivlighn SD, 36:189 Kopecka L, 36:199 Kopecky J, 36:199 O Kvétina J, 36:199 Oh GT, 36:33, 36:163 Onishi K, 35:55 Osborn JW, 35:45 L Lacarelle B, 35:211 Lacroix P, 35:139 P Langley RW, 36:77 Page RL, 35:173 Lautt WW, 35:77 Palazzoadriano M, 35:107 Le Rumeur E, 35:139 Palmeira CM, 35:35 Le Tallec N, 35:139 Pang H, 35:121 Legare DJ, 35:77 Paterna S, 35:107 Pellegrini A, 35:131 Sterz F, 35:203 Percicot CL, 36:223 Stétinova V, 36:199 Peri G, 36:21 Szabadi E, 36:77 Perillo MA, 35:69 Pierce TL, 36:137 T Takasuna K, 35:25 Q Tamolang MB, 35:121 Queen K, 36:171 Tamura K, 35:19 Tillig B, 35:191 Togna AR, 35:153 R Togna G, 35:153 Rabin RA, 36:81 Trafny EA, 36:73 Ranaei RA, 36:189 Trejtnar F, 36:199 Raper C, 36:137 Tritthart HA, 35:203 Rapoport RM, 36:81 Trzeciakowski JP, 36:103 Raval P, 35:31 Ren Y, 35:121 Riazi-Farzad B, 35:217 U Richelson E, 35:11 Ueda Y, 35:55 Rimele T, 36:171 Usui C, 35:25 Riviere JE, 35:173 Robinson J, 36:155 Rodger IW, 35:179 V ROnnhedh C, 36:123 Vaden SL, 35:173 Rose D, 36:171 Van Loon GW, 36:97 Rossi V, 36:21 Villard PH, 35:211 Vukomanovic DV, 36:97 S Santajuliana D, 35:45 W Sarkadi A, 35:145 Wallace KB, 35:35 Sasaki T, 35:19 Wasan KM, 36:1 Scatizzi R, 35:131 Wiesel M-L, 36:69 Schnell CR, 36:223 Wong PY, 35:121 Schnellmann RG, 36:41 Woods JH, 35:223 Schroeder K, 36:155 Schudt C, 35:91 Schumacher WA, 35:3 X Schiimann K, 36:211 Xie H, 35:77 Schwarzl |, 36:205 Sekioka K, 35:55 Seligmann B, 36:155 Semecky V, 36:199 Y Sesnie JC, 36:185 Yamada M, 35:11 Severin CM, 36:81 Yun Y-P, 36:33 Sewell RD, 35:217 Shapiro MA, 36:185 Spencer PSJ, 35:1 Z Stark G, 36:205 Zernig G, 35:223 Stark U, 35:203, 36:205 Zhang YL, 35:77 Steinbacher TE, 35:3 Zhu L, 35:77 Stella C, 35:153 Zoutman DE, 36:97 wast AM s4 “ ELSEVIER Subject Index Volumes 35 and 36 A Apoptosis ACE inhibition, comparing different inhibitors of renin- rapid fluorescence assay for LDH release and, 36:44 angiotensin system, 35:83 sodium nitroprusside and, 35:11 Acetylcholine, aortic multiple-ring preparation for Arterial pressure, ganglionic blockade protocol to functional studies and, 35:131 assess neurogenic pressor activity and, 35:45 Acidic drugs, bile-exteriorized rat as source of acyl Arterial thrombosis, aspirin and, 35:3 glucuronides and, 36:131 Aspirin, arterial thrombosis and, 35:3 Acyl glucuronides, bile-exteriorized rat as source of, Atrial flutter, simulated, 35:203 36:131 AV node Adaptation, intestinal transfer in isolated intestinal rate-dependent effects of verapamil, diltiazem, and segments, 36:211 digoxin on, 36:205 Adenosine nucleotidase, vascular endothelial ADPase simulated atrial flutter and, 35:203 activity evaluation and, 35:153 ADP, vascular endothelial ADPase activity evaluation, 35:153 B a,-Adrenoceptors, rat ileum effects, 36:147 Benzodiazepine, osmotic minipumps and, 36:29 Alfentanil, calculation of agonist efficacy and apparent Bifurcations, stimulus-response analysis and, 36:103 in vivo affinity, 35:223 Bile-exteriorized rats, acyl glucuronides source, Alpha-chymotrypsin, radio-telemetry system to record 36:131 intraocular pressure and, 36:223 Bioenergetics, mitochondria membrane potential, p-Aminohippurate, renal function measurement and, 35:35 36:189 Bladder, videomicroscopic imaging of peristalsis, Amphotericin B 35:191 lipoprotein composition and, 36:1 Blood-brain barrier, cerebral microvascular endothelial nephrotoxicity, 36:199 cells and in vitro drug transport, 36:45 Analgesia, calculation of agonist efficacy and apparent Blood coagulation, aspirin and, 35:3 in vivo affinity, 35:223 Blood pressure Annamycin, lipoprotein composition and, 36:1 comparing different inhibitors of renin-angiotensin Anti-convulsant activity assessment, electroshock and, system and, 35:83 35:25 heparin-filled catheter and, 36:69 Antibody responses, SH assay and, 36:33 Bovine aorta, vascular endothelial ADPase activity Antimicrobial agents, in vitro model to test efficacy evaluation and, 35:153 Bovine serum albumin, binding affinity constants of of , 36:73 Antinociception, calculation of agonist efficacy and soluble ligand-receptor complex and, 35:69 apparent in vivo affinity, 35:223 Bronchoalveolar lavage (BAL), leukocyte differentiation Antithrombotic and thrombolytic activity, reproducible and, 35:91 model in rats, 35:101 Aorta multiple-ring preparation for functional studies, 35: C 131 Calcium transient, myocardial ischemia and, 35:55 nitric oxide-sensitive electrode and, 35:19 Carbachol [(?H]Apafant, binding to rabbit platelet membranes, nitric oxide-sensitive electrode and, 35:19 36:53 rat stomach fundus and, 35:217 Journal of Pharmacological and Toxicological Methods 36, 233-238 (1996) © 1996 Elsevier Science Inc. 1056-8719/96/$15.00 655 Avenue of the Americas, New York, NY 10010 Carboxyhemoglobin level, tobacco smoke intoxication Diclofenac, PGE, effects on trachea and, 36:63 and, 35:211 Digoxin, myocardial ischemia and, 35:55 Cardiac muscle, mathematical model of isometric Dimethylformamide, effects on in vivo fatigue and contraction of isolated, 36:171 metabolism, 35:139 Cardiac relaxation, mathematical model of isometric Dioxin, antibody production measurement and, 36:33 contraction of isolated cardiac muscle, 36:171 Dissociation constant, binding affinity constants of Carotid artery thrombosis, reproducible model in rats, soluble ligand-receptor complex, 35:69 35:101 Dopamine, soman intoxication and, 35:159 Cat, insulin sensitivity test with euglycemic technique, Dorsal hand vein, dose-reponse curves to 35:77 noradrenaline and, 36:77 Catheterization, blood pressure and heparin-filled Dorsal raphe nucleus, pargyline on 5-HT binding in, catheter, 36:69 36:81 Cell death, rapid fluorescence assay for LDH release Dose-reponse curves, noradrenaline effects, 36:77 and, 36:44 Drug delivery, osmotic minipumps and chronic, 36:29 Cell-signaling, stimulus-response analysis and, 36:103 Drug-specific binding, rate-dependent effects of Charcoal adsorption, radioimmunoassay optimized for verapamil, diltiazem, and digoxin on AV node, reproducible measurement of rat plasma insulin, 36:205 35:111 Dyslipidemia, hydrophobic drugs and, 36:1 Charcoal-extracted plasma, radioimmunoassay optimized for reproducible measurement of rat E plasma insulin, 35:111 Effective renal plasma flow, determination, 36:189 Chlorisondamine, neurogenic pressor activity and, Efficacy 35:45 calculation of agonist efficacy and apparent in vivo Cholinergic nerves, drug effects, 36:147 affinity, 35:223 Chronic drug delivery, osmotic minipumps and, 36:29 stimulus-response analysis and, 36:103 Cisplatin, isolated perfused tumor and skin flap model [7H]8-OH-DPAT, binding to DRN, 36:81 and, 35:173 Electric damage, reproducible model of arterial Collagen dressing, in vitro model to test efficacy of thrombosis in rats and, 35:101 antimicrobial agents, 36:73 Electroencephalographic activity, quantitative Contraction, dimethylformamide effects on in vivo evaluation in rats, 35:145 fatigue and metabolism in skeletal muscle, 35:139 Electroshock, seizure test, 35:25 Cumulative dose-reponse curves, noradrenaline Endothelium effects, 36:77 aortic multiple-ring preparation for functional Cyclosporin A, nephrotoxicity, 36:199 studies and, 35:131 Cyclosporin G, chromatographic separation, 35:121 rat brain endothelial culture and in vitro drug Cyclosporin metabolites, chromatographic separation, transfer, 36:45 35:121 Endothelium-dependent relaxation, nitric oxide- Cyclosporine, lipoprotein composition and, 36:1 sensitive electrode and, 35:19 Cynomolgus monkeys, analysis of IL-1 antagonists, Enteric nerves, drug effects, 36:147 36:155 Euglycemic technique, insulin sensitivity test with, Cytochrome P450, chromatographic separation of 35:77 cyclosporin G metabolites and, 35:121 Ex vivo model, analysis of IL-1 antagonists, 36:155 Cytotoxicity fixation procedure of leukemia cells in sulforhodamine B cytotoxicity assay, 36:163 F mitochondria membrane potential, 35:35 Fast Atom Bombardment Mass Spectrometry, chromatographic separation of cyclosporin G metabolites, 35:121 D FCS, antibody production measurement and, 36:33 Daytime variability, visual-evoked responses and Ferret, arterial thrombosis, 35:3 electroencephalographic activity evaluation in rats [(?H]5-HT, binding to DRN, 36:81 and, 35:145 5-HT, rat stomach fundus and, 35:217 Dependence, induction and quantitation of 5-HT,, receptor, binding to DRN, 36:81 methadone, 36:137 Flunitrazepam, binding affinity constants of soluble Diazepam, osmotic minipumps and, 36:29 ligand-receptor complex and, 35:69 Fluorescence assay, LDH release, 36:44 Infarct size, experimental myocardial ischemic and FMLP-induced aggregation, 36:21 reperfusion injury and, 35:179 Inositol, cardiac level determination, 35:107 Inotropy, mathematical model of isometric contraction of isolated cardiac muscle and, 36:171 G Insulin sensitivity test, modified euglycemic technique GABA, soman intoxication and, 35:159 for, 35:77 Glaucoma, radio-telemetry system to record Intact animals, cardiac inositol level measurement, intraocular pressure in, 36:223 35:107 Glomerular filtration rate, determination, 36:189 Intestinal absorption, intestinal transfer in isolated Glucose, insulin sensitivity test with, 35:77 intestinal segments, 36:211 Glycopeptide, antibody production measurement and, Intraocular pressure, radio-telemetry system to record, 36:33 36:223 Guinea pigs Inulin, renal function and, 36:189 comparing different inhibitors of renin-angiotensin lothalamate, urineless renal clearance and, 36:123 system, 35:83 Ischemia, cardiac inositol level measurement and, leukocyte differentiation in bronchoalveolar lavage 35:107 (BAL), 35:91 Ischemic myocardium, experimental reperfusion injury mathematical model of isometric contraction of and, 35:179 isolated cardiac muscle, 36:171 Isolated heart, working, 35:63 Isolated perfused tumor and skin flap model, cisplatin and, 35:173 H Isolated perfusion, cisplatin and, 35:173 Half-life, mRNA, 35:31 Iterative maps, stimulus-response analysis and, 36:103 Hamsters, ear swelling test and local lymph node assay assessment in, 35:167 Heart, isolated perfused working, 35:63 K Heparin-filled catheter, blood pressure and, 36:69 Kinetic, rate-dependent effects of verapamil, diltiazem, Hepatic enzymate activities, tobacco smoke and digoxin on AV node, 36:205 intoxication and, 35:211 Hexamethonium, neurogenic pressor activity and, 35:45 L HI-6, soman intoxication and, 35:159 Lactate dehydrogenase, fluorescence assay for, 36:44 High performance liquid chromatography (HPLC) Left ventricular function, myocardial ischemia and, paf-acether in human blood and, 35:121 35:55 separation of cyclosporin G metabolites, 35:121 Leukemia cells, fixation procedure in sulforhodamine Hydrogen peroxide, sodium nitroprusside and, 35:11 B cytotoxicity assay, 36:163 Leukocyte differentiation, bronchoalveolar lavage (BAL) and, 35:91 I Lipid transfer protein, hydrophobic drugs and, 36:1 IFN-B, mRNA levels, 35:31 Lipopaf, paf-acether in human blood and, 35:121 IL-1, analysis of IL-1 antagonists, 36:155 Lipoproteins, hydrophobic drugs and, 36:1 IL-1ra, analysis of IL-1 antagonists and, 36:155 Local lymph node assay, assessment of ear swelling Imaging, videomicroscopic imaging of peristalsis and, test and, 35:167 35:191 Longitudinal and circular muscle, drug effects, 36:147 Impedance planimetry, coronary artery Lyapunov exponents, stimulus-response analysis and, pharmacodynamics and, 36:13 36:103 In vitro, intestinal transfer in isolated intestinal segments, 36:211 In vitro model, antimicrobial agents efficacy and, M 36:73 Magnetic resonance spectroscopy, dimethylformamide In vivo affinity, calculation of agonist efficacy and effects on in vivo fatigue and metabolism apparent, 35:223 measured by 31P-, 35:139 Increasing-current, electroshock, 35:25 Mathematical model, isometric contraction of isolated Indomethacin, FMLP-induced aggreagation and, 36:21 cardiac muscle, 36:171 Methadone, induction and quantitation of Nonlinear dynamics, stimulus-response analysis and, dependence, 36:137 36:103 Methods, 5-HT and carbachol in subsections of rat Nonsteroidal anti-inflammatory drugs (NSAIDs), FMLP- stomach fundus strip, 35:217 induced aggreagation and, 36:21 Mice Noradrenaline, dose-reponse curves to, 36:77 assessment of local lymph node assay and mouse Norepinephrine, aortic multiple-ring preparation for ear swelling test, 35:167 functional studies and, 35:131 electroshock seizure test, 35:25 Nystatin, lipoprotein composition and, 36:1 intestinal transfer in isolated intestinal segments, 36:211 O novel rapid throughput phototolerance screen in Ocular hypertension, radio-telemetry system to record mice, 36:185 intraocular pressure and, 36:223 tobacco smoke intoxication effects on Oncosis, rapid fluorescence assay for LDH release carboxyhemoglobin and hepatic enzymate and, 36:44 activities in, 35:211 Operational model, calculation of agonist efficacy and Microplate filtration system, [*H]apafant binding to apparent in vivo affinity, 35:223 rabbit platelet membranes, 36:53 Opioids, calculation of agonist efficacy and apparent Milrinone, myocardial ischemia and, 35:55 in vivo affinity, 35:223 Mitochondria, membrane potential, 35:35 Osmotic minipumps, diazepam and, 36:29 Modeling, calculation of agonist efficacy and apparent Oxazolone, ear swelling test and local lymph node in vivo affinity, 35:223 assay assessment, 35:167 Monkeys, analysis of IL-1 antagonists and cynomolgus, 36:155 Monoamine oxidase, binding to DRN, 36:81 P Morphine, calculation of agonist efficacy and apparent PAF receptor binding, [?H]Apafant and, 36:53 in vivo affinity, 35:223 Para-aminohippurate, urineless renal clearance and, Mouse ear swelling test, assessment of local lymph 36:123 node assay and, 35:167 PCR reactions, IFN-B MRNA, 35:31 mRNA, half-life determination, 35:31 PFC assay, antibody production measurement and, Multiple-ring, aortic multiple-ring preparation for 36:33 functional studies, 35:131 PGE,, effects on trachea, 36:63 Muscle mechanics, mathematical model of isometric Phosphatidylcholine, paf-acether in human blood and, contraction of isolated cardiac muscle, 36:171 35:121 Myocardial ischemia, calcium transport and left Photically evoked afterdischarge, visual-evoked ventricular function in, 35:55 responses and electroencephalographic activity evaluation in rats and, 35:145 N Phototolerance, novel rapid throughput phototolerance Naloxone-precipitated withdrawal, induction and screen in mice, 36:185 quantitation of methadone dependence and, Phrases, rapid fluorescence assay for LDH release, 36:137 36:41 Nephrotoxicity, xenobiotics, 36:199 Plasma insulin, radioimmunoassay optimized for Neuroblastoma, sodium nitroprusside and, 35:11 reproducible measurement of rat, 35:111 Neurogenic pressor activity, ganglionic blockade Platelet aggregation, aspirin and, 35:3 protocol to assess, 35:45 Potassium, coronary artery pharmacodynamics and, Neutrophil accumulation, experimental myocardial 36:13 ischemic and reperfusion injury and, 35:179 Potassium dichromate, ear swelling test and local Nifedipine, coronary artery pharmacodynamics and, lymph node assay assessment, 35:167 36:13 Pro-convulsant activity assessment, electroshock and, Nitric oxide keFe -sensitive electrode, 35:19 Protein kinase C, measurement in blood vessels, 36:87 sodium nitroprusside and, 35:11 Pseudomonas aeruginosa Nitric oxide pyocyanin analysis by adsorptive stripping -sensitive electrode, 35:19 voltammetry and, 36:73 Noncumulative dose-reponse curves, noradrenaline in vitro model to test efficacy of antimicrobial effects, 36:77 agents and, 36:73 R Renal pelvis, videomicroscopic imaging of peristalsis Rabbit platelet membranes, [*H]Apafant binding to, and, 35:191 36:53 Renin-angiotensin system, comparing different Rabbits, radio-telemetry system to record intraocular inhibitors, 35:83 pressure, 36:223 Renin inhibition, comparing different inhibitors of Radioimmunoassay renin-angiotensin system, 35:83 chromatographic separation of cyclosporin G Reperfusion injury, experimental ischemic metabolites, 35:121 myocardium and, 35:179 reproducible measurement of rat plasma insulin Rifampicin, chromatographic separation of cyclosporin G metabolites and, 35:121 and, 35:111 Rapid filtration, binding affinity constants of soluble ligand-receptor complex and, 35:69 S Rapid screening method, novel rapid throughput Seizure threshold, electroshock, 35:25 phototolerance screen in mice, 36:185 Rat ileum, drug effects, 36:147 Serial determination, urineless renal clearance, 36:123 Serotonin receptor, pargyline on 5-HT binding in Rat stomach fundus, 5-HT and carbachol in, 35:217 dorsal raphe nucleus, 36:81 Rate dependency SH assay, antibody production measurement and, effects of verapamil, diltiazem, and digoxin on 36:33 atrioventricular conduction, 36:205 Skeletal muscle, dimethylformamide effects on in vivo simulated atrial flutter and, 35:203 fatigue and metabolism, 35:139 Rats Smooth muscle, protein kinase C translocation, 36:87 bile-exteriorized rat as source of acyl glucuronides, Sodium nitroprusside, cellular death via, 35:11 36:131 Soluble ligand-receptor complex, binding affinity blood pressure and heparin-filled catheter, 36:69 constants of, 35:69 cerebral microvascular endothelial cells and in vitro Solvent, dimethylformamide effects on in vivo fatigue drug transport, 36:45 and metabolism, 35:139 drug effects on ileum, 36:147 Soman, intoxication, 35:159 insulin sensitivity test with euglycemic technique, Spare receptors, calculation of agonist efficacy and 35:77 apparent in vivo affinity, 35:223 intestinal transfer in isolated intestinal segments, SRB assay, fixation procedure of human leukemia 36:211 cells, 36:163 isolated working heart model, 35:63 Staphylococcus aureus, in vitro model to test efficacy leukocyte differentiation in bronchoalveolar lavage of antimicrobial agents and, 36:73 (BAL), 35:91 Stasis, reproducible model of arterial thrombosis in renal function measurement without radioisotopes, rats and, 35:101 36:189 Statistics, mathematical model of isometric contraction reproducible model of arterial thrombosis, 35:101 of isolated cardiac muscle, 36:171 soman intoxication, 35:159 Stimulus amplication, stimulus-response analysis and, urineless renal clearance, 36:123 36:103 visual-evoked responses and Sucklings, intestinal transfer in isolated intestinal electroencephalographic activity evaluation, segments, 36:211 35:145 Sulforhodamine B cytotoxicity assay, fixation Reactivity, bile-exteriorized rat as source of acyl procedure of human leukemia cells, 36:163 glucuronides and, 36:131 Receptor reserve, calculation of agonist efficacy and apparent in vivo affinity, 35:223 T Refractoriness, simulated atrial flutter and, 35:203 TCA, fixation procedure of leukemia cells in Renal blood flow, determination, 36:189 sulforhodamine B cytotoxicity assay, 36:163 Renal cells, rapid fluorescence assay for LDH release Thin-layer chromatography (TLC), paf-acether in and, 36:44 human blood and, 35:121 Renal clearance, urineless, 36:123 Threshold phenomenon, stimulus-response analysis Renal function, determination, 36:189 and, 36:103 Renal hypertension, comparing different inhibitors of Thromboxane inhibitor, arterial thrombosis and, 35:3 renin-angiotensin system and, 35:83 Time constant rate-dependent effects of verapamil, diltiazem, and Vv digoxin on AV node, 36:205 Vascular endothelial ADPase, activity evaluation, simulated atrial flutter and, 35:203 35:153 Tissue culture, in vitro drug transport and, 36:45 Vascular smooth muscle, nitric oxide-sensitive Tobacco smoke intoxication, effects on electrode and, 35:19 carboxyhemoglobin and hepatic enzymate Vasoconstriction, coronary artery pharmacodynamics activities, 35:211 and, 36:13 Trachea, PGE, effects on, 36:63 Ventricular rate, simulated atrial flutter and, 35:203 Translocation, protein kinase C in smooth muscle, Videomicrometry, PGE, effects on trachea and, 36:63 36:87 Visual-evoked potential, quantitative evaluation in rats, Transmural stimulation, rat ileum and, 36:147 35:145 Transport, cerebral microvascular endothelial cells and Voltammetric, adsorptive stripping, 36:97 in vitro drug, 36:45 Trimethaphan, neurogenic pressor activity and, 35:45 WwW Triphenyltetrazolium stain, experimental myocardial Working, heart model, 35:63 ischemic and reperfusion injury and, 35:179 Tube preparation, PGE, effects on trachea and, 36:63 Y Yohimbine-induced dysrhythmias, isolated working U heart model and, 35:63 Ureter, videomicroscopic imaging of peristalsis and, 35:191 Urineless renal clearance, 36:123 Z Urodynamics, videomicroscopic imaging of peristalsis, Zomepirac, bile-exteriorized rat as source of acyl 35:191 glucuronides and, 36:131